![](/img/cover-not-exists.png)
Cytotoxicity of the novel anti-cancer drug rViscumin depends on HER-2 levels in SKOV-3 cells
Shaker Abuharbeid, Jürgen Apel, Martin Sander, Babette Fiedler, Martin Langer, Mary-Lou Zuzarte, Frank Czubayko, Achim AignerVolume:
321
Year:
2004
Language:
english
Pages:
413
DOI:
10.1016/j.bbrc.2004.06.160
File:
PDF, 560 KB
english, 2004